T78248
Nesvacumab
TargetMol
DESCRIPTION
Nesvacumab, a fully human immunoglobulin G1 (IgG1) monoclonal antibody, selectively binds to and inactivates Angiopoietin-2 (Ang2), the ligand for the Tie2 receptor, with high affinity, while exhibiting no affinity for Angiopoietin-1 (Ang1) [1].
DETAILS
- Cas: 1296818-77-3
- Purity: 98%
- Category: Compound
Lead Time: 4 - 5 weeks
Sign in to view pricingEquivalent Items
| ... Loading